We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+2.99%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$4.36B
AUM Growth
+$1.42B
Cap. Flow
+$2.09B
Cap. Flow %
47.88%
Top 10 Hldgs %
44.57%
Holding
147
New
40
Increased
52
Reduced
12
Closed
36

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$86.1M
2
TJX icon
TJX Companies
TJX
+$75.5M
3
TVTX icon
Travere Therapeutics
TVTX
+$65.1M
4
AMZN icon
Amazon
AMZN
+$63.1M
5
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$52.3M

Top Sells

Rank Stock Value
1
LNTH icon
Lantheus
LNTH
+$45.4M
2
ORLY icon
O'Reilly Automotive
ORLY
+$41M
3
ULTA icon
Ulta Beauty
ULTA
+$39.7M
4
FIVE icon
Five Below
FIVE
+$38M
5
FTDR icon
Frontdoor
FTDR
+$32.9M

Sector Composition

Rank Sector Weight
1 Healthcare 46.59%
2 Consumer Staples 10.1%
3 Consumer Discretionary 9.65%
4 Technology 2.31%
5 Industrials 1.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRTS icon
126
CarParts.com
PRTS
$46.9M
– –
-55,000
Closed -$6.82M
RNAC icon
127
Cartesian Therapeutics
RNAC
$257M
– –
-54,533
Closed -$4.96M
ROST icon
128
Ross Stores
ROST
$81.6B
– –
-212,284
Closed -$26.1M
TGT icon
129
Target
TGT
$66.8B
– –
-178,687
Closed -$31.5M
ULTA icon
130
Ulta Beauty
ULTA
$23.2B
– –
-138,304
Closed -$39.7M
VFC icon
131
VF Corp
VFC
$5.8B
– –
-49,781
Closed -$4.25M
VTRS icon
132
Viatris
VTRS
$19B
– –
-936,000
Closed -$17.5M
VXRT
133
DELISTED
Vaxart
VXRT
– –
-145,523
Closed -$831K
CYTH
134
DELISTED
Cyclo Therapeutics, Inc. Common Stock
CYTH
– –
-100,000
Closed -$435K
CYTHW
135
DELISTED
Cyclo Therapeutics, Inc. Warrant
CYTHW
– –
-50,000
Closed -$156K
SMAR
136
DELISTED
Smartsheet Inc.
SMAR
– –
-82,000
Closed -$5.68M
MOTS
137
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
– –
-1,157
Closed -$329K
NEPT
138
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
– –
-2,976
Closed -$6.5M
AVTA
139
DELISTED
Avantax, Inc. Common Stock
AVTA
– –
-1,328,000
Closed -$21.1M
KBNTW
140
DELISTED
Kubient, Inc. Warrant
KBNTW
– –
-275,000
Closed -$1.11M
LMNL
141
DELISTED
Liminal BioSciences Inc. Common Shares
LMNL
– –
-56,524
Closed -$2.37M
TMDI
142
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
– –
-278,787
Closed -$477K
STAB
143
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
– –
-320,053
Closed -$1.1M
CLVS
144
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-2,256,000
Closed -$10.8M
SRGA
145
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
– –
-14,533
Closed -$955K
PTE
146
DELISTED
PolarityTE, Inc. Common Stock
PTE
– –
-67,569
Closed -$1.15M
BXRX
147
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
– –
-2,505
Closed -$3.54M
2 3 4 5
6

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q1 2021 Portfolio in Review

As of Q1 2021, Armistice Capital held 147 positions worth $4.36B, up 48% from $2.94B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Armistice Capital deployed $2.09B of net new capital in Q1 2021, opening 40 new positions and adding to 52 existing holdings. Its largest new stake was Vertex Pharmaceuticals: 392,000 shares worth $84.2M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, down from 48% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

On the sell side, the largest reduction was Lantheus, an estimated $45.4M trimmed.

  • Armistice Capital's largest Q1 2021 buy was Vertex Pharmaceuticals: 392,000 shares worth $84.2M.
  • Armistice Capital added most to Amazon in Q1 2021, an estimated $63.1M increase.
  • Armistice Capital's biggest Q1 2021 reduction was Lantheus, cutting an estimated $45.4M.
  • Armistice Capital fully exited O'Reilly Automotive in Q1 2021, selling an estimated $41M.
  • Armistice Capital's ten largest holdings make up 45% of its $4.36B portfolio in Q1 2021.
  • Armistice Capital opened 40 new positions and closed 36 in Q1 2021.
  • Armistice Capital's portfolio value rose 48% quarter-over-quarter to $4.36B.

Based on Armistice Capital's 13F filing for Q1 2021, filed 17 May 2021.